KNOTUS CoLtd (Korea) Today
| 278650 Stock | KRW 2,185 25.00 1.16% |
Performance0 of 100
| Odds Of DistressLess than 9
|
KNOTUS CoLtd is trading at 2185.00 as of the 26th of November 2024, a 1.16 percent increase since the beginning of the trading day. The stock's open price was 2160.0. KNOTUS CoLtd has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for KNOTUS CoLtd are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2024 and ending today, the 26th of November 2024. Click here to learn more.
It offers platform technology services, such as cell-enzyme-based screening, xenograft assay, mitogenic effect test, vaccine antigen, antibody titration, cytokine, MRNA expression, trachea relaxation assay, carrageenan, adjuvant induced paw edema, antipyretic, anti-pain test, isolated blood vessel screening, fibrin plate lysis screening, ferric chloride induced model, food diet induced model, gastric acid secretion, emesis model, MIC test, post antibody effect, enzyme assay, systemic, local infection model, PK study, chemical, transgenic animal, osteoblast-like cell line screening, bone formation marker, and biomarker. More on KNOTUS CoLtd
Moving together with KNOTUS Stock
Moving against KNOTUS Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
KNOTUS Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. KNOTUS CoLtd's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding KNOTUS CoLtd or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology & Medical Research, Healthcare (View all Sectors) |
KNOTUS CoLtd (278650) is traded on KOSDAQ in Korea and employs 164 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 336.43 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate KNOTUS CoLtd's market, we take the total number of its shares issued and multiply it by KNOTUS CoLtd's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. KNOTUS CoLtd operates under Healthcare sector and is part of Biotechnology & Medical Research industry.
KNOTUS CoLtd has accumulated about 6.16 B in cash with 8.46 B of positive cash flow from operations.
Check KNOTUS CoLtd Probability Of Bankruptcy
Ownership AllocationThe market capitalization of KNOTUS CoLtd is W336.43 Billion. KNOTUS CoLtd holds noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check KNOTUS Ownership Details
KNOTUS CoLtd Risk Profiles
Although KNOTUS CoLtd's alpha and beta are two of the key measurements used to evaluate KNOTUS CoLtd's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.02 | |||
| Standard Deviation | 3.09 | |||
| Variance | 9.53 | |||
| Risk Adjusted Performance | (0.05) |
KNOTUS Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in KNOTUS CoLtd without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Other Information on Investing in KNOTUS Stock
KNOTUS CoLtd financial ratios help investors to determine whether KNOTUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KNOTUS with respect to the benefits of owning KNOTUS CoLtd security.